MASI Masimo
- 116.160
- -5.600-4.60%
- 116.500
- +0.340+0.29%
Masimo News
The Masimo Corporation (NASDAQ:MASI) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Shareholders might have noticed that Masimo Corporation (NASDAQ:MASI) filed its quarterly result this time last week. The early response was not positive, with shares down 8.9% to US$124 in the past w
Activist Politan Capital Rejects Masimo Offer for One Board Seat
Politan Capital Management Proposes To Add Darlene Solomon And Bill Jellison To Masimo's Board Immediately
Politan Capital Management Proposes To Add Darlene Solomon And Bill Jellison To Masimo's Board Immediately
UPDATE 1-Masimo Says Prepared to Provide One Board Seat to Activist Politan
Masimo Proposes Settlement With Activist Politan
By Ben Glickman Masimo has proposed a settlement with activist investor Politan Capital, which would involve the hedge fund controlling half of the company's board seats. In a letter to Quentin Koff
Masimo: Response From Politan Capital Management Expected by May 10
Masimo: Response From Politan Capital Management Expected by May 10
Masimo: Jellison Appointment Contingent on Politan Withdrawing Other Nominee, Dropping Proxy Contest
Masimo: Jellison Appointment Contingent on Politan Withdrawing Other Nominee, Dropping Proxy Contest
Masimo Prepared to Appoint Politan Nominee William R. Jellison to Board, Letter Says
Masimo Prepared to Appoint Politan Nominee William R. Jellison to Board, Letter Says
Masimo First Quarter 2024 Earnings: Beats Expectations
Masimo Activist Director Koffey Demands 'basic' Information on Company's Proposed Spinoff
Masimo activist Quentin Koffey says he'll pursue litigation if the health-tech company doesn't provide information on a proposed spinout of a business unit. Koffey said the company demanded directors sign a non-disclosure agreement to get basic information on the deal. Koffey won a seat on Masimo's board in a 2023 proxy battle, and is expected to pursue a second fight for additional control.
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing around 0.3%. The iShares Biotechnology ETF (IBB
Sector Update: Health Care
Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing 0.3%. The iShares Biotechnology ETF (IBB) decre
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue guidance below estim
Update: Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set; Shares Fall
(Updates with stock movement in headline and first paragraph.) Masimo (MASI) shares were down 12.4% in recent Wednesday trading, a day after the company reported Q1 non-GAAP net income of $0.77 per di
Masimo Corporation (NASDAQ:MASI) Q1 2024 Earnings Call Transcript
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
Masimo Shares Are Trading Lower Following Q1 Earnings. The Company's Q2 Guidance Midpoint Was Below Consensus Estimates.
Masimo Shares Are Trading Lower Following Q1 Earnings. The Company's Q2 Guidance Midpoint Was Below Consensus Estimates.
Earnings Call Summary | Masimo(MASI.US) Q1 2024 Earnings Conference
The following is a summary of the Masimo Corporation (MASI) Q1 2024 Earnings Call Transcript:Financial Performance:Masimo reported a Q1 consolidated revenue of $493 million, underpinned by $340 millio
Masimo to Present in BofA Securities Health Care Conference
Masimo Price Target Raised to $126.00/Share From $117.00 by Piper Sandler
Masimo Price Target Raised to $126.00/Share From $117.00 by Piper Sandler
Analysis
Price Target
No Data
